Pre-Open Stock Movers

Plantronics (NYSE: PLT) 30% LOWER; reported Q3 EPS of $0.30, $0.16 better than the analyst estimate of $0.14. Revenue for the quarter came in at $392 million versus the consensus estimate of $400.51 million. Plantronics sees Q4 2020 EPS of ($0.36)-$0.19, versus the consensus of $0.51. Plantronics sees Q4 2020 revenue of $354-394 million, versus the consensus of $441 million.

Arbutus Biopharma (NASDAQ: ABUS) 16.7% HIGHER; JMP Securities upgraded from Market Perform to Market Outperform with a price target of $10.00.

Knowles (NYSE: KN) 14% LOWER; reported Q4 EPS of $0.35, $0.05 worse than the analyst estimate of $0.40. Revenue for the quarter came in at $233.9 million versus the consensus estimate of $237.61 million.

Ziopharm Oncology, Inc. (Nasdaq: ZIOP) 12.4% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Ziopharm. Ziopharm also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the number of shares of common stock offered in the public offering at the public offering price, less underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Coty (NYSE: COTY) 10.9% HIGHER; reported Q2 EPS of $0.27, $0.03 better than the analyst estimate of $0.24. Revenue for the quarter came in at $2.35 billion versus the consensus estimate of $2.34 billion.

Boot Barn Holdings (NYSE: BOOT) 10.5% LOWER; reported Q3 EPS of $0.81, $0.01 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $284 million versus the consensus estimate of $282.41 million. Boot Barn Holdings sees FY2020 EPS of $1.81-$1.83, versus the consensus of $1.82.

Ford Motor (NYSE: F) 9.7% LOWER; reported Q4 EPS of $0.12, $0.03 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $39.7 billion versus the consensus estimate of $36.49 billion.

Match Group (NASDAQ: MTCH) 8% LOWER; reported Q4 EPS of $0.45, $0.01 better than the analyst estimate of $0.44. Revenue for the quarter came in at $547.17 million versus the consensus estimate of $552.89 million.

Qiagen (NYSE: QGEN) 7.7% HIGHER; reported Q4 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $413.5 million versus the consensus estimate of $408.58 million. Qiagen sees FY2020 EPS of $1.52-$1.54, versus the consensus of $1.49.

New Relic (NYSE: NEWR) 7.3% LOWER; reported Q3 EPS of $0.09, $0.03 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $153 million versus the consensus estimate of $149.18 million. New Relic sees Q4 2020 EPS of $0.02-$0.06, versus the consensus of $0.08. New Relic sees Q4 2020 revenue of $154-156 million, versus the consensus of $155.06 million. New Relic sees FY2020 EPS of $0.54-$0.59, versus the consensus of $0.64. New Relic sees FY2020 revenue of $594-596 million, versus the consensus of $591.05 million.

Aimmune Therapeutics, Inc. (Nasdaq: AIMT) 7% HIGHER; announced that Nestle Health Science will make an additional equity investment in Aimmune of $200 million, bringing Nestle's total investment in Aimmune to date to $473 million.

SolarWinds (NYSE: SWI) 6.6% LOWER; reported Q4 EPS of $0.24, $0.02 better than the analyst estimate of $0.22. Revenue for the quarter came in at $249.4 million versus the consensus estimate of $251.7 million.

Snap (NYSE: SNAP) 6.4% LOWER; reported Q4 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $561 million versus the consensus estimate of $563.03 million. Snap sees Q1 2020 revenue of $450-470 million, versus the consensus of $461.63 million.

KLA Corporation (NASDAQ: KLAC) 4.8% LOWER; reported Q2 EPS of $2.66, $0.08 better than the analyst estimate of $2.58. Revenue for the quarter came in at $1.51 billion versus the consensus estimate of $1.48 billion.

Halozyme Therapeutics (NASDAQ: HALO) 4.7% HIGHER; Piper Sandler upgraded from Neutral to Overweight with a price target of $27.00 (from $18.00).

Unum Group (NYSE: UNM) 4% HIGHER; reported Q4 EPS of $1.41, $0.03 better than the analyst estimate of $1.38. Revenue for the quarter came in at $3.03 billion versus the consensus estimate of $3.02 billion.

Fiserv Inc (NASDAQ: FISV) 3.2% LOWER; reported Q4 EPS of $1.13, $0.01 worse than the analyst estimate of $1.14. Revenue for the quarter came in at $3.71 million versus the consensus estimate of $3.8 million. Fiserv Inc sees FY2020 EPS of $4.86-$5.02, versus the consensus of $4.97.

Chubb Corp. (NYSE: CB) 3% HIGHER; reported Q4 EPS of $2.28, $0.16 better than the analyst estimate of $2.12.

Red Rock Resorts (NASDAQ: RRR) 2.7% LOWER; reported Q4 EPS of $0.05, $0.19 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $460.8 million versus the consensus estimate of $463.23 million.

Cerner (NASDAQ: CERN) 1.6% HIGHER; reported Q4 EPS of $0.75, $0.01 better than the analyst estimate of $0.74. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.44 billion. Cerner sees Q1 2020 EPS of $0.69-$0.71, versus the consensus of $0.70. Cerner sees Q1 2020 revenue of $1.415-1.465 billion, versus the consensus of $1.43 billion. Cerner sees FY2020 EPS of $3.09-$3.19, versus the consensus of $3.14. Cerner sees FY2020 revenue of $5.725-5.975 billion, versus the consensus of $5.91 billion.

Nike (NYSE: NKE) 1.4% LOWER; announces approximately half of NIKE-owned stores have been temporarily closed in China